NCT03023995

Brief Summary

Over the years, numerous surgical techniques such as free autografts and pedicle grafts have been introduced to correct gingival recession defects. Combination grafts with either autografts or allografts, and newer concepts of guided tissue regeneration (GTR), platelet concentrates, etc., were developed more recently to correct mucogingival defects. The use of PRF in various surgical procedures such as degree II furcations, intrabony defects, sinus floor segmentation during implant placement and on facial plastic surgeries have shown promising results. However to our knowledge, till this study was completed, no studies have been reported with the clinical outcomes of autologous platelet rich fibrin membrane for the treatment of localized gingival recession defects. Hence, this study was designed to compare coronally advanced flap with platelet rich fibrin membrane versus subepithelial connective tissue graft in treatment of Miller's Class I and Class II gingival recession defects.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Aug 2015

Shorter than P25 for phase_3

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 11, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 18, 2017

Completed
Last Updated

January 18, 2017

Status Verified

January 1, 2017

Enrollment Period

1 year

First QC Date

January 11, 2017

Last Update Submit

January 13, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reduction in recession depth

    Recession depth reduction from baseline to 6 months

    Baseline to 6 months

Secondary Outcomes (4)

  • Reduction in Mean plaque scores

    baseline to 6 months

  • Reduction in mean gingival scores

    Baseline to 6 months

  • Width of keratinised tissue

    baseline to 6 months

  • Change Relative attachment level

    baseline to 6 months

Study Arms (2)

CAF with Platelet Rich Fibrin

EXPERIMENTAL

In test group, preparation of PRF was carried out, after which the flap was coronally positioned over the membrane to completely cover it.

Procedure: CAF with Platelet rich fibrin

CAF with connective tissue graft

ACTIVE COMPARATOR

In control group, connective tissue graft harvesting was carried out which was followed by placement of connective tissue graft on the recipient site. The connective tissue graft was placed on the recipient site and secured in position with 5-0 vicryl sutures

Procedure: CAF with connective tissue graft

Interventions

In test group, preparation of PRF was carried out, after which the flap was coronally positioned over the membrane to completely cover it and secured with 4-0 non resorbable sutures.

CAF with Platelet Rich Fibrin

In control group, connective tissue graft was harvested, after which the flap was coronally positioned over the graft to completely cover it and secured with 4-0 non resorbable.

CAF with connective tissue graft

Eligibility Criteria

Age20 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male and female patients with age group between 20 to 55 years,
  • Presence of bilateral Millers Class I or II gingival recession defects,
  • Periodontally healthy patients,
  • Patient who demonstrate acceptable oral hygiene status prior to surgical procedure,
  • Patient with a medium to deep palatal vault (for Control Group only),
  • Patients agreed to give informed consent

You may not qualify if:

  • History of prolonged use of antibiotics / steroids /immunosuppressive agents/aspirin/anticoagulants/other medications,
  • Pregnant women,
  • Smokers,
  • History of systemic diseases like hypertension, diabetes, HIV, bone metabolic disorders, radiation therapy, immunosuppressive therapy, cancer, etc.
  • Patients with unacceptable oral hygiene,
  • Faulty tooth brushing technique,
  • Mal-aligned tooth,
  • Cervical abrasion,
  • Teeth with prominent roots.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Gingival Recession

Condition Hierarchy (Ancestors)

Gingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPeriodontal Atrophy

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

January 11, 2017

First Posted

January 18, 2017

Study Start

August 1, 2015

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

January 18, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share